1. Home
  2. STTK vs MYFW Comparison

STTK vs MYFW Comparison

Compare STTK & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STTK
  • MYFW
  • Stock Information
  • Founded
  • STTK 2016
  • MYFW 2002
  • Country
  • STTK United States
  • MYFW United States
  • Employees
  • STTK N/A
  • MYFW N/A
  • Industry
  • STTK Biotechnology: Pharmaceutical Preparations
  • MYFW Major Banks
  • Sector
  • STTK Health Care
  • MYFW Finance
  • Exchange
  • STTK Nasdaq
  • MYFW Nasdaq
  • Market Cap
  • STTK 173.6M
  • MYFW 169.4M
  • IPO Year
  • STTK 2020
  • MYFW 2018
  • Fundamental
  • Price
  • STTK $3.86
  • MYFW $19.27
  • Analyst Decision
  • STTK Strong Buy
  • MYFW Buy
  • Analyst Count
  • STTK 3
  • MYFW 3
  • Target Price
  • STTK $10.67
  • MYFW $20.67
  • AVG Volume (30 Days)
  • STTK 150.7K
  • MYFW 17.6K
  • Earning Date
  • STTK 11-07-2024
  • MYFW 10-17-2024
  • Dividend Yield
  • STTK N/A
  • MYFW N/A
  • EPS Growth
  • STTK N/A
  • MYFW N/A
  • EPS
  • STTK N/A
  • MYFW 0.36
  • Revenue
  • STTK $4,123,999.00
  • MYFW $80,146,000.00
  • Revenue This Year
  • STTK $164.45
  • MYFW N/A
  • Revenue Next Year
  • STTK N/A
  • MYFW $11.04
  • P/E Ratio
  • STTK N/A
  • MYFW $51.93
  • Revenue Growth
  • STTK 380.09
  • MYFW N/A
  • 52 Week Low
  • STTK $1.33
  • MYFW $12.84
  • 52 Week High
  • STTK $11.76
  • MYFW $21.15
  • Technical
  • Relative Strength Index (RSI)
  • STTK 57.18
  • MYFW 61.02
  • Support Level
  • STTK $3.37
  • MYFW $18.39
  • Resistance Level
  • STTK $3.75
  • MYFW $19.19
  • Average True Range (ATR)
  • STTK 0.24
  • MYFW 0.68
  • MACD
  • STTK 0.08
  • MYFW 0.16
  • Stochastic Oscillator
  • STTK 88.57
  • MYFW 95.61

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

Share on Social Networks: